
|Articles|October 23, 2007
FDA extends deadline for e-prescribing comments
Dec. 6 is new deadline for public comments regarding electronic distribution of prescribing information for Rx drugs.
Advertisement
Apparently not satisfied with the volume of comments it has received, the FDA has extended the comment period regarding electronic distribution of prescribing information for prescription drug products. The new deadline for comments, as published in the Oct. 22
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Gaps Between Expectations and Effects on Long COVID Contribute to Trust in Vaccines
2
PCV21 Shows Cost Effectiveness Compared With PCV15, PCV13, and PPSV23
3
American Pharmacists Month: How Community Pharmacy Innovation Relies on Expansion, Collaboration
4
Pharmacies Should Be Proactive in Expanding Clinical Services, Reimbursement Pathways | NCPA 2025
5


























































































































































